Various transgressions are detailed in the letters, including implying that medicines were FDA-evaluated for safety or FDA-approved, using phrases like "clinically proven" in promotions, claiming to be the manufacturer when in fact another organisation is making the drugs, and misleading advertising
Disclosure: Im a paid contributor to NutritionNC.com and was not compensated by Coby for this review
Specific pathways affected include TGF-beta superfamily signaling, Wnt signaling, antioxidant defense (including superoxide dismutase, glutathione S-transferases, and thioredoxin reductase), and DNA repair mechanisms
2 Many diabetes patients who take GLP-1 medications lose a smaller amount of weight than patients who take GLP-1 medications and do not have diabetes
enm-2024-2164-Supplemental-Fig-S1.pdf Supplemental Fig
This does not prove effectiveness, but it reduces the risk of mislabeled doses and contaminants